Clinical Trial Update: Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing pentostatin, cyclophosphamide, and rituximab with or without bevacizumab in patients with chronic lymphocytic leukemia or small lymphocy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Avastin (bevacizumab)
• Cytoxan (cyclophosphamide)
• NIPENT (pentostatin)
• Rituxan (rituximab)

Snippet

Sponsor: Mayo Clinic | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2014-05-09